Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ambulatory, array, assure, attention, BAX, biopharmaceutical, candidate, China, Coagulant, Coagulation, consummation, contemplated, continuum, council, create, CRRT, customer, divert, divestiture, EMA, entitled, gene, greater, holder, home, III, infusor, innovative, intended, introduced, Irvine, legacy, listed, membership, memorandum, modest, outlining, pattern, perioperative, Poor, prophylactic, proposed, protein, PSU, publicly, pursue, registration, reversal, rigosertib, Round, routine, satisfying, settled, size, spent, submission, substantive, swap, temporary, timeline, typically, Unanticipated, undertook, USDC, volume
Removed:
advancing, antibody, appealed, assembled, austerity, bankruptcy, began, bridge, broad, broader, Care, category, Circuit, clinic, closing, complementary, computer, congenital, consolidate, consolidating, contaminant, Corrupt, covering, creditor, declined, deductible, denied, Department, design, designed, determination, device, disease, dismissed, documentation, entity, European, excise, execute, failure, finance, Food, footprint, forma, Greek, guidance, hospital, implement, industry, infringement, initiative, inquiry, invalidity, invest, investigated, irreversible, Justice, kidney, license, light, loan, maturing, modified, Momenta, monitoring, October, operation, outsourcing, owner, people, porcine, preferred, Prism, pro, realization, remain, requesting, rpFVIII, secured, standardize, suffered, sufficiency, supplying, technical, testing, transitioned, workforce
Filing tables
Filing exhibits
Related press release
BAX similar filings
Filing view
External links
EXHIBIT 15
April 30, 2014
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Commissioners:
We are aware that our report dated April 30, 2014 on our review of interim financial information of Baxter International Inc. (the “company”) for the three-month periods ended March 31, 2014 and 2013 and included in the company’s quarterly report on Form 10-Q for the quarter ended March 31, 2014 is incorporated by reference in its Registration Statements on Form S-8 (Nos. 333-43563, 333-47019, 333-88257, 333-48906, 333-62820, 333-102140, 333-104420, 333-104421, 333-105032, 333-143063, 333-174400 and 333-174401) and on Form S-3 (Nos. 333-123811 and 333-183099).
Very truly yours,
/s/ PricewaterhouseCoopers LLP
Chicago, Illinois